Can low testosterone be continually monitored through Medicare funded blood tests when it’s not clinically necessary?

I understand that if a patient is under the care of an endocrinologist for low testosterone, Tx would qualify the patient for a repeat MBS funded pathology testing as a formal hypogonadism diagnosed with the relevant under 6 nmol/l blood tests and any other investigations have confirmed disease. But what about online clinics where Tx is prescribed at higher than MBS regulatory levels (above 6) at the Drs discretion. More a wellness type service. Would MBS funded pathology monitoring be justified in these cases? As not strictly medically necessary treatment but more for well-being.